Tribute Pharmaceuticals Canada Inc. Watch

ended 06/30/15 Q2 2015 – amended

ended 09/30/15 Q3

ended 06/30/15 Q2

ended 03/31/15 Q1

ended 12/31/14 FY 2014

Securities registration termination

Exempt offering of securities

Exempt offering of securities

Updated info for already-effective prospectus

Updated info for already-effective prospectus

Flynn James E

Fmr LLC

Fmr LLC

Elora Financial Management Inc.

Harris Robert Paul

Material Definitive Agreement, Termination of Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, New Financial Obligation or Off-Balance Sheet Arrangement, Increase/Acceleration of Financial Obligation or Off-Balance Sheet Arrangement, Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Change of Control

Pozen and Tribute Combine to Create Aralez Pharmaceuticals Inc

Announces Results of Shareholder Vote

Leading Independent Advisors Recommend That Tribute Shareholders Vote FOR the Transaction

Mails Materials in Connection With Special Meeting of Shareholders to Approve Transaction With Pozen and Encourages Shareholders to Vote

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Letter from the SEC

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Confidential treatment order